Prescription medications can be a significant financial burden, especially for those who are uninsured or underinsured. Recognizing this challenge, Johnson & Johnson (formerly Janssen Pharmaceuticals) has established the Johnson & Johnson Patient Assistance Foundation, Inc. (JJPAF), a nonprofit organization dedicated to providing eligible patients with free prescription medicines.
How the patient assistance program works
The Johnson & Johnson Patient Assistance Program offers access to 35 prescription products for individuals who meet specific eligibility requirements and reside in the United States or a U.S. Territory. Applying for the program is free and requires completing a single application form. Once approved, patients can receive their medications for up to one year, with the possibility of reapplying annually.
Applying for the Johnson & Johnson Patient Assistance Programs
To apply for the Johnson & Johnson Patient Assistance Programs, individuals need to complete a straightforward application form. The application process is free, and applicants only need to submit one application to be considered for multiple medications.
The application form will require applicants to provide personal and financial information. This information is necessary to determine eligibility based on income guidelines and residency requirements. Once the application is submitted, it will be reviewed by the foundation, and applicants will be notified of their eligibility status. Patient Assistance Program Application (jjpaf.org)
Eligibility criteria for the Patient Assistance Program
To determine eligibility for the Johnson & Johnson Patient Assistance Program, certain requirements must be met. While the specific criteria may vary depending on the medication, common factors considered for eligibility include:
To be eligible for the Johnson & Johnson Patient Assistance Program, patients must have been prescribed medication that is donated by a Johnson & Johnson operating company. This program specifically caters to individuals who require Johnson & Johnson medications for their treatment.
Meeting the income requirements is an essential criterion for qualifying for the Patient Assistance Program. Johnson & Johnson has established specific income guidelines that patients must meet to be eligible for free prescription medications. These income requirements may vary depending on the type of medication and the patient’s household size. It is crucial to review the income requirements outlined by Johnson & Johnson to determine if you meet the criteria.
To be eligible for the Johnson & Johnson Patient Assistance Program, enrollees must not have any form of health insurance, including government or private insurance. This program is designed to support individuals who do not have access to insurance coverage for their medications. Patients who have insurance coverage, whether it is through government programs or private providers, may not qualify for the program.
The Johnson & Johnson Patient Assistance Program is available to individuals residing in the United States or a U.S. Territory. To qualify for this program, patients must provide proof of their residency in the United States or a U.S. Territory. It is important to note that this program is not available to individuals residing outside of the United States or U.S. Territories.
To be eligible for the Patient Assistance Program, patients must be under the outpatient care of a U.S.-licensed doctor. This means that the patient’s treatment must be overseen by a doctor who holds a valid license to practice medicine in the United States. Patients receiving inpatient care or treatment from doctors who are not licensed in the United States may not be eligible for the program.
Access to a wide range of medications
The Johnson & Johnson Patient Assistance Programs offer access to a diverse range of prescription medications. With over 35 products available, patients can receive the treatments they need at no cost if they meet eligibility requirements. Below are the drugs available and links to their savings options:
- AKEEGA™ (niraparib and abiraterone acetate) Tablets
- BALVERSA® (erdafitinib) Tablets
- DARZALEX® (daratumumab) Injection for intravenous infusion
- DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) injection for subcutaneous use
- EDURANT® 1 (rilpivirine) Tablets
- ELMIRON® (pentosan polysulfate sodium) Capsules
- ERLEADA® (apalutamide) Tablets
- IMBRUVICA® (ibrutinib) Capsules/Tablets/Oral Suspension
- Infliximab †Intravenous Infusion
- INVEGA HAFYERA® † (paliperidone palmitate) Extended-Release Injectable Suspension
- INVEGA SUSTENNA® † (paliperidone palmitate) Extended-Release Injectable Suspension
- INVEGA TRINZA® † (paliperidone palmitate) Extended-Release Injectable Suspension
- INVOKAMET® † 1 (canagliflozin/metformin HCI) Tablets
- INVOKAMET® XR † 1 (canagliflozin/metformin HCI) Extended-Release Tablets
- INVOKANA® 1 (canagliflozin) Tablets
- MONOVISC® (high molecular weight hyaluronan) Injection
- OPSUMIT® † (macitentan) Tablets
- ORTHOVISC® (high molecular weight hyaluronan) Injection
- PONVORY™ (ponesimod) Tablets
- PREZCOBIX® 1 (darunavir 800mg/cobicistat 150mg) Tablets
- PREZISTA® 1 (darunavir) Tablets/Oral Suspension
- REMICADE® † (infliximab) IV Infusion
- RISPERDAL CONSTA® † (risperidone) Long-Acting Injection
- RYBREVANT® (amivantamab-vmjw) Injection
- SIMPONI® † (golimumab) Injection
- SIMPONI ARIA® † (golimumab) IV Infusion
- SIRTURO® † (bedaquiline) Tablets
- SPRAVATO® † (esketamine) Nasal Spray, for intranasal use, CIII
- STELARA® (ustekinumab) Injection, for subcutaneous or intravenous use
- SYMTUZA® † (darunavir, cobicistat, emtricitabine, and tenofovir alafenamide) Tablets
- TALVEY™ † (talquetamab-tgvs) Injection, for subcutaneous use
- TECVAYLI® † (teclistamab-cqyv) Injection, for subcutaneous use
- TRACLEER® † (bosentan) Tablets
- TREMFYA® (guselkumab) Injection, for subcutaneous use
- UPTRAVI® (selexipag) Tablets
- VELETRI® (epoprostenol) Injection
- XARELTO® † 1 (rivaroxaban) Tablets or Oral Suspension
- YONDELIS® (trabectedin) Injection for intravenous infusion
Companies supporting the Patient Assistance Programs
The Johnson & Johnson Patient Assistance Foundation is made possible through the generosity of several donor drug maker companies within the Johnson & Johnson family. These companies include:
- Actelion Pharmaceuticals US, Inc.
- DePuy Synthes Mitek Sports Medicine, a division of DePuy Orthopaedics, Inc.
- Janssen Biotech, Inc.
- Janssen Therapeutics, Division of Janssen Products, LP
- Janssen Pharmaceuticals, Inc.
The commitment and support of these companies enable the foundation to provide free prescription medications to eligible patients.
Prescription drug savings programs, such as the Johnson & Johnson Patient Assistance Programs, are invaluable resources for individuals who face financial barriers to accessing necessary medications. By providing free prescription medicines to eligible patients, Johnson & Johnson and its donor companies demonstrate their commitment to improving access to healthcare.
Through these programs, individuals can receive the medications they need to manage their health conditions effectively, without experiencing the additional burden of high costs. The Johnson & Johnson Patient Assistance Programs truly make a difference in the lives of patients and contributes to a more equitable healthcare system.
NowPatient has taken all reasonable steps to ensure that all material is factually accurate, complete, and current. However, the knowledge and experience of a qualified healthcare professional should always be sought after instead of using the information in this page. Before taking any drug, you should always speak to your doctor or another qualified healthcare provider.
The information provided here about medications is subject to change and is not meant to include all uses, precautions, warnings, directions, drug interactions, allergic reactions, or negative effects. The absence of warnings or other information for a particular medication does not imply that the medication or medication combination is appropriate for all patients or for all possible purposes.
WHY WE BUILT NOWPATIENT
To improve the lives of everyone by making high-quality care accessible and convenient
We are here to improve lives. Our service gives you access to smart features and resources that can help empower you to take control of your health and improve your health outcomes. All this, in one place, for FREE. We strive to bring a fresh perspective to managing health. NowPatient can be accessed by downloading the App or using your web browser.
Download our app today
Can I trust NowPatient
Meet our medical review team
Trustworthy and reliable medical content authored and reviewed by our experienced team of medical professionals from the United Kingdom and the United States. Learn more about our team and our editorial process by clicking on the buttons below.